{"id":"W4393164331","doi":"10.1007/s40257-024-00853-4","title":"Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"National Center for Advancing Translational Sciences; AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); Clinical trial; Pharmacotherapy; Pediatrics; Internal medicine; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006353671,0.0003679495,0.005257184,0.0003404421,0.00004807299,0.00004919978,0.000128157,0.0002607664,0.000005822437],"category_scores_gemma":[0.01144772,0.0002431884,0.0002122735,0.0003019858,0.001971143,0.0002487564,0.0000827542,0.001002113,6.566502e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001706797,"about_ca_system_score_gemma":0.0006600578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003840761,"about_ca_topic_score_gemma":0.0002063414,"domain_scores_codex":[0.9875105,0.005726278,0.00530707,0.0006354194,0.0004331087,0.0003876235],"domain_scores_gemma":[0.9889439,0.007847285,0.001757668,0.0002683271,0.0003613393,0.0008214776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4196073,0.0004646222,0.5447603,0.0003484667,0.0008024892,0.0009027358,0.001006534,0.000001557448,0.000005271186,0.00004300632,0.00009712486,0.03196049],"study_design_scores_gemma":[0.4955357,0.00184555,0.4942094,0.004113816,0.0006426112,0.000922139,0.001360235,0.0007956903,0.00001381215,0.0002627889,0.00003101305,0.0002672139],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912205,0.003611015,0.0004564821,0.003289883,0.0002120864,0.001084239,0.00008241975,0.00001717318,0.00002616623],"genre_scores_gemma":[0.9964852,0.001353363,0.000382031,0.001620252,0.00009019137,0.00001877599,0.00001372774,0.00002761775,0.000008875708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07592835,"threshold_uncertainty_score":0.9968793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05139782894144093,"score_gpt":0.4066843368383661,"score_spread":0.3552865078969252,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}